Oral bioavailability in Beagle dog assessed as 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethanol level at 2 mg/kg by...

Basic Information

ID: ALA4367412

Type: ADME

Description: Oral bioavailability in Beagle dog assessed as 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethanol level at 2 mg/kg by LC/MS/MS analysis

Format: BAO_0000218

Organism: Canis lupus familiaris

Strain: Beagle

Target: ADMET(ALA612558)

Document: ALA4364295

Oral bioavailability in Beagle dog assessed as 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethanol level at 2 mg/kg by LC/MS/MS analysis: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA4367412

Total(1)

Parent Molecular Weight	ALogP	Polar Surface Area
580.64	4.04	4.04

Parent Molecular Weight

ALogP

Polar Surface Area

580.64

4.04

Oral bioavailability in Beagle dog assessed as 2-((4-(Benzo[d]thiazol-5-ylamino)-6-(tert-butylsulfonyl)quinazolin-7-yl)oxy)ethanol level at 2 mg/kg by...

Basic Information

Activity Charts

Compound Summary